Cerezyme ratings & reviews

Cerezyme is a brand name for imiglucerase, which is a hydrolytic lysosomal enzyme produced by recombinant DNA technology. This drug is formulated as a sterile lyophilized powder for injection, intended for intravenous use, with each vial containing 424 units of imiglucerase. Key inactive ingredients include mannitol, polysorbate 80, and sodium citrates. It is commonly used to treat conditions related to enzyme deficiencies, such as Gaucher disease, by replacing deficient enzymes and reducing lipid buildup in tissues.

How should I use this medication?

This medication is infused into a vein. It is given by your care team in a hospital or clinic setting.

Talk to your care team the use of this medication in children. While it may be prescribed for children as young as 2 years for selected conditions, precautions do apply.

Overdosage: If you think you have taken too much of this medicine contact a poison control center or emergency room at once.

NOTE: This medicine is only for you. Do not share this medicine with others.

What if I miss a dose?

Keep appointments for follow-up doses. It is important not to miss your dose. Call your care team if you are unable to keep an appointment.

Where should I keep my medication?

This medication is given in a hospital or clinic. It will not be stored at home.

NOTE: This sheet is a summary. It may not cover all possible information. If you have questions about this medicine, talk to your doctor, pharmacist, or health care provider.

What side effects may I notice from receiving this medication?

Side effects that you should report to your care team as soon as possible:

• Allergic reactions or angioedema—skin rash, itching or hives, swelling of the face, eyes, lips, tongue, arms, or legs, trouble swallowing or breathing

Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):

• Back pain
• Dizziness
• Fatigue
• Headache
• Nausea

This list may not describe all possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What should I tell my care team before I take this medication?

They need to know if you have any of these conditions:

• An unusual or allergic reaction to imiglucerase, other medications, foods, dyes, or preservatives
• Pregnant or are trying to get pregnant
• Breastfeeding

What may interact with this medication?

• Miglustat

This list may not describe all possible interactions. Give your health care provider a list of all the medicines, herbs, non-prescription drugs, or dietary supplements you use. Also tell them if you smoke, drink alcohol, or use illegal drugs. Some items may interact with your medicine.

What should I watch for while using this medication?

Visit your care team for regular checks on your progress. Tell your care team if your symptoms do not start to get better or if they get worse.

This medication can cause serious allergic reactions. To reduce the risk, your care team may give you other medications to take before receiving this one. Follow the directions from your care team.

What are the most serious risks of this medication?

Serious side effects may occur during and after the infusion of this medication. Your care team will watch you closely. Tell your care team right away if you have a skin rash, itching, hives, swelling of the face, tongue, arms, or legs, trouble breathing, fast or irregular heartbeat, or feel faint or lightheaded.